Suraj Kalia
Stock Analyst at Oppenheimer
(3.06)
# 1,264
Out of 5,116 analysts
86
Total ratings
45.95%
Success rate
11.77%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Outperform | $175 | $95.47 | +83.30% | 3 | Dec 8, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $23 → $18 | $11.83 | +52.16% | 7 | Nov 19, 2025 | |
| EW Edwards Lifesciences | Downgrades: Perform | n/a | $86.85 | - | 6 | Oct 8, 2025 | |
| PRCT PROCEPT BioRobotics | Upgrades: Outperform | $60 | $32.41 | +85.13% | 2 | Sep 2, 2025 | |
| PLSE Pulse Biosciences | Initiates: Outperform | $22 | $14.40 | +52.78% | 1 | Jul 7, 2025 | |
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $124.20 | +20.77% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $40.33 | +11.58% | 7 | Feb 13, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $176.60 | -32.05% | 6 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $46.31 | -30.90% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $83.78 | +11.01% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $130 | $124.84 | +4.13% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $10 | $6.87 | +45.56% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $4.47 | +190.83% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $78.88 | +71.15% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $244.76 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $29.66 | +1.15% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $320 → $200 | $0.75 | +26,488.67% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $83.61 | +16.01% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $24.90 | +12.45% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $3.85 | +16.88% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.07 | +1,395.33% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $577.81 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $1.74 | +37,831.03% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $2.86 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $19.38 | +416.00% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $67.57 | - | 5 | Sep 12, 2018 |
Inspire Medical Systems
Dec 8, 2025
Upgrades: Outperform
Price Target: $175
Current: $95.47
Upside: +83.30%
Varex Imaging
Nov 19, 2025
Maintains: Outperform
Price Target: $23 → $18
Current: $11.83
Upside: +52.16%
Edwards Lifesciences
Oct 8, 2025
Downgrades: Perform
Price Target: n/a
Current: $86.85
Upside: -
PROCEPT BioRobotics
Sep 2, 2025
Upgrades: Outperform
Price Target: $60
Current: $32.41
Upside: +85.13%
Pulse Biosciences
Jul 7, 2025
Initiates: Outperform
Price Target: $22
Current: $14.40
Upside: +52.78%
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $124.20
Upside: +20.77%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $40.33
Upside: +11.58%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $176.60
Upside: -32.05%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $46.31
Upside: -30.90%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $83.78
Upside: +11.01%
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $124.84
Upside: +4.13%
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $6.87
Upside: +45.56%
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $4.47
Upside: +190.83%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $78.88
Upside: +71.15%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $244.76
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $29.66
Upside: +1.15%
Jun 23, 2023
Maintains: Outperform
Price Target: $320 → $200
Current: $0.75
Upside: +26,488.67%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $83.61
Upside: +16.01%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $24.90
Upside: +12.45%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $3.85
Upside: +16.88%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $1.07
Upside: +1,395.33%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $577.81
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $1.74
Upside: +37,831.03%
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $2.86
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $19.38
Upside: +416.00%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $67.57
Upside: -